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Dose–response associations between cycling activity and risk
of hypertension in regular cyclists: The UK Cycling for
Health Study
M Hollingworth1, A Harper1 and M Hamer2
Most population studies on physical activity and health have involved largely inactive men and women, thus making it difﬁcult
to infer if health beneﬁts occur at exercise levels above the current minimum guidelines. The aim was to examine associations
between cycling volume and classical cardiovascular risk markers, including hypertension and hypercholesterolemia, in a
population sample of habitual cyclists. A nationwide sample comprising 6949 men and women (aged 47.6 years on average)
completed questions about their cycling levels, demographics and health. Nearly the entire sample (96.3%) achieved the current
minimum physical activity recommendation through cycling alone. There was a dose–response association between cycling
volume and risk of diagnosed hypertension (P-trend = 0.001), with odds ratios of 0.98 (95% conﬁdence interval (CI), 0.80–1.21), 0.86
(0.70, 1.06), 0.67 (95% CI, 0.53–0.83) across categories of 23–40, 40–61 and 461 metabolic equivalent hours/week (MET-h/week)
compared with o23 MET-h/week. These associations persisted in models adjusted for age, sex, smoking, alcohol, body mass index
(BMI) and other moderatevigorous physical activities. We also observed inverse associations between cycling volume and other risk
factors including BMI and hypercholesterolemia. In summary, results from a population sample of cyclists suggest that additional
cardiovascular health beneﬁts can be achieved beyond the current minimum physical activity recommendation.
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INTRODUCTION
Physical inactivity is thought to account for over £8 billion per year
in healthcare costs in the UK alone.1 In order to minimise the
public health implications of physical inactivity, it is important to
understand the relationship between physical activity and the
associated health beneﬁts; central to this is the determination of
dose–response relationships. The majority of population-based
evidence to date on the cardiovascular health beneﬁts of physical
activity has been generated using broad physical activity
questionnaires that have rarely considered effects for speciﬁc
types of activities.2,3
Cycling is an affordable, environmentally friendly and accessible
means of activity,4 but our understanding of the health beneﬁts
are limited. Lusk et al.5 demonstrated a direct relationship
between weight loss and cycling 0–5 and 15–45min per day,
while others have shown consistent increases in ﬁtness measure-
ments during the ﬁrst 6 months of cycling interventions.6
However, cycling beyond these parameters were not associated
with added health beneﬁts. Indeed, Hoevenaar-Blom et al.,7 found
no added cardiovascular health beneﬁts cycling less than
3.5 h/week versus cycling more than 3.5 h/week. The small
numbers of participants and artiﬁcial study environments used
in these studies both limit their statistical power and relevance to
current cycling habits, which has prevented the determination of a
dose–response relationship between cycling and health outcome.
However, large observational cross-sectional studies into the
health of recreational runners have been successful in demon-
strating such dose–response relationships.8–12 The National
Runners’ Health Study, which recruited over 100 000 participants,
observed signiﬁcant associations between high weekly mileage
and lower usage of anti-hypertensive and cholesterol-lowering
medications8 in addition to lower incidence of type II diabetes
mellitus,9 coronary heart disease10 and stroke.11 Furthermore,
higher running intensities were also associated with reduced risk
factors for cardiovascular disease.12
The Cycling for Health UK Study aimed to conduct an
observational cross-sectional study to analyse cycling activity in
a large cohort of cyclists to determine dose–response associations
between cycling activity and classical cardiovascular risk
markers, including body mass index (BMI), hypertension and
hypercholesterolemia.
MATERIALS AND METHODS
Study design and participants
The study design was based on The National Runners’ Health Study.8
We designed an online survey and participants were recruited into the
study in 2013. A link to the survey was advertised via various national UK
cycling bodies including the national cycling charity, the CTC, British
Cycling, Sky Ride, Cycling Weekly and Cycling Fitness magazine. In addition
we used other forms of social media, such as a study twitter account
(@cyclinghealthUK) to recruit participants into the study. The aim was to
capture participants from a variety of cycling backgrounds ranging from
commuters to amateur racing cyclists. The study gained ethical approval
from the University College London Graduate School Ethics Committee.
By completing the questionnaire participants implied their consent to take
part in the study.
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Survey measures
The survey included questions on demographics (age, sex and education),
cycling history (number of years cycling, average weekly total cycling
distance, time, speed and best times for various standard distance
competitive cycling races), weight, height, resting heart rate (self-recorded
at the radial artery from the ventral aspect of the wrist), alcohol intake,
current and past cigarette use, history of cardiovascular events (heart
attacks, stroke) and cancer and medications/ physician diagnosis for
hypertension, high cholesterol or diabetes. Participation in non-cycling
physical activities was also collected using the International Physical
Activity Questionnaire.13
Statistical analysis
Average cycling speed was converted into MET using the compendium of
physical activities,14 and further multiplied by weekly cycling time to
provide a measure of total cycling volume (MET-h/week). We used linear
regression to examine associations between cycling volume and
continuous dependent variables. We used multiple logistic regression to
compute odds ratios (ORs) with accompanying 95% conﬁdence intervals
(CIs) for the association between cycling volume and diagnosed
hypertension/hypercholesterolemia. For these analyses cycling volume
was further categorised into four equal groups. The models were adjusted
for potential confounding factors, including age (categorised into 10 year
age bands), sex, smoking (never; previous; current), weekly alcohol intake
(0 units; 1–10 units; 11–21 units; above 21 units), BMI (normal weight,
BMIo25; overweight, BMI 25–30; obese, BMI ⩾ 30 kgm− 2) and lastly for
other moderate–vigorous physical activities (zero h/week; 1–3;43–7;47).
Analyses were conducted using SPSS version 21 (Chicago, IL, USA).
RESULTS
Participant characteristics
7006 participants completed the survey and after cleaning the
data a sample size of 6949 was used in the present analysis.
Participants providing implausible data (for example, cycling
456 h/week) were removed. The characteristics of the sample
are provided in Table 1. The age of the sample ranged from
16–88 years old, they were largely male (75.6%), and on average
cycled 4 days per week expending 45.5 MET-h/week on cycling
alone (Table 1). Nearly the entire sample (96.3%) achieved
the current minimum physical activity recommendation
(7.5 MET-h/week) through cycling alone. Men consistently
replorted higher cycling volumes than women across the age
strata. There was a trend for decreasing cycling volume with age
in men, but this pattern was not observed in women (Figure 1).
The age differences were largely explained by lower cycling speed
(see Supplementary Table S1).
Validation of cycling activity
Resting heart rate is commonly used to validate physical activity
assessment, since bradycardia is a cardiac manifestation of aerobic
conditioning. We observed a statistically signiﬁcant inverse
relationship between reported cycling volume and resting heart
rate (Figure 2). Each MET-h/week of cycling was associated with
− 0.07 beats per min (bpm) (95% CI, − 0.08, − 0.06) reduction after
adjusting for age and sex.
Association with cardiovascular risk factors
We observed a signiﬁcant inverse relationship between reported
cycling volume and BMI (Figure 3). Each MET-h/week of cycling
was associated with 0.020 kgm− 2 (95% CI, 0.023–0.017) lower BMI
after adjusting for age and sex. There was a dose-dependent
association between cycling volume and risk of diagnosed
hypertension (Table 2), and the highest category of cycling was
associated with a 0.67 (95% CI, 0.53–0.83) lower odds in age and
sex adjusted analyses. These associations persisted in fully
adjusted models. A similar pattern of results was obtained in
relation to hypercholesterolemia (Table 3). To ensure results were
not confounded by differences in contact with health-care
services, we analysed associations between cycling activity and
visits to primary care over the previous year. We did not
demonstrate any association between cycling activity and visits
to primary care, suggesting our results were not confounded by
differences in health-care usage.
Sensitivity analyses
We repeated the analysis after removing 186 participants
reporting prior history of a cardiovascular event or angina,
Table 1. Descriptive characteristics of the sample (N= 6949)
Characteristic Mean average Range
Age 47.6 16–88
% Men 75.6
% smokers 3.6
Body mass index 25.02 15–76
Days per week cycling 4.2 1–7
Years of cycling 21.6 0–78
MET-h/week cycling 45.5 0–300
Other moderate–vigorous physical activity
(h/week)
3.4 0–28
Abbreviation: MET-h/week, metabolic equivalent hours/week.
Figure 1. Average weekly cycling volume measured by metabolic
equivalent (MET-h per week) in men and women in o30, 30–40, 41–
50, 51–60 and 60+ age groups.
Figure 2. Average resting heart rate measured by beats per min
(bpm) in men and women organised by cycling volume ⩽ 23.3,
23.21–40, 40.01–61.2 and461.2 MET-h/week. Data adjusted for age.
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although the associations remained largely unchanged. For
example, the highest cycling volume category was associated
with a 0.66 (95% CI, 0.52–0.83) lower odds of diagnosed
hypertension and 0.70 (95% CI, 0.56–0.88) lower odds of
hypercholesterolemia in age and sex adjusted models.
We ran additional models to explore associations between
‘other physical activities’ and hypertension. In age and sex
adjusted models there was an inverse association between
moderate—vigorous physical activity and risk of hypertension
(P-trend = 0.04). For example, in relation to 0 h per week
(reference), participants reporting 1–3, 3–7, and 47 h/week
demonstrated odds of 0.82 (95% CI, 0.65–1.03), 0.71 (0.56–0.90),
0.81 (0.61–1.07). Nevertheless, these associations did not
persist after adjusting for other covariables and cycling volume
(P-trend = 0.13).
We also explored associations between ‘cycle commuting’ and
hypertension. A sub-sample of N= 2253 reported using their bike
to commute. In models adjusted for age, sex, smoking, weekly
alcohol intake, BMI and other physical activities, there was an
inverse association between commuting and risk of hypertension.
For example, in relation to o15.75 MET-h/week (reference),
participants reporting 15.8–27, 27.1–40 and 440 MET-h/week
demonstrated odds of 0.78 (95% CI, 0.51–1.17), 0.74 (0.48–1.13)
and 0.65 (0.42–1.01), respectively. We did not, however, observe
any associations between commuting and BMI (data not shown).
Lastly, we modelled age and sex interaction terms by cycling
volume although they were not signiﬁcant. For example, we
observed similar dose–response trends for anti-hypertensive
effects of cycling in both sexes; men (age adjusted OR= 0.71,
0.56–0.90) and women (0.42, 0.20–0.87) that reported the highest
cycling volumes were at the lowest risk of hypertension.
DISCUSSION
We analysed data from 6949 regular cyclists regarding cycling
volume and cardiovascular risk factors. According to the current
physical activity guidelines, the vast majority (96.3%) of the
sample met the criteria for adequate physical activity based on
cycling alone. Despite this, we demonstrated clear health beneﬁts
of physical activity over and above the minimum guidelines.
Indeed, we demonstrated an inverse, dose–response relationship
between cycling volume and risk of diagnosed hypertension and
hypercholesterolemia suggesting that higher cycling volumes
offer greater health beneﬁts. The associations for cycling were
independent of other forms of physical activity.
Our study population were exclusively regular cyclists with
high-activity levels. The extent to which this can be applied to the
wider population is limited. However, even within this active
population we managed to identify key trends in cardiovascular
risk factors in relation to cycling activity. This is in contrast to
previous experimental studies that have failed to demonstrate
sustained trends in health beneﬁts for increasing doses.5,6 It must
be acknowledged that our data relies on self-reported cardiovas-
cular risk factors and cycling activity, which may have invited bias.
The validity of self-reported height and weight as a continuous
variable is mixed,15 and the speciﬁcity for recall of hypertension
and hypercholesterolemia is good.16 Nevertheless, we cannot rule
out the possibility of undiagnosed hypertension. We cannot
completely control for biases regarding participants’ personal
health perception; however, following analysis of visits to primary
care services, we did not ﬁnd any evidence to show a link between
cycling activity and usage of primary care suggesting more active
cyclists were not less likely to seek medical treatment. It has been
problematic to validate self-reported cycling activity largely
because of the inability of objective movement sensors (accel-
erometers) to accurately detect cycling; however, our demonstra-
tion of decreasing resting heart rate with increasing cycling
volume is suggestive of a physiological bradycardia, which reﬂects
higher levels of cardiovascular ﬁtness. In addition, many cyclists
use cycling computers and are thus able to recall speed, distance
and time more accurately. It is important to acknowledge
the limitations of our observational cross-sectional design. Our
statistical analyses help to control for important confounding
variables, but our observational (cross-sectional) design prevent us
from inferring causality. Despite this, the Bradford-Hill considera-
tions describe the importance of biological gradients in describing
causality in epidemiological data,17 and thus our ﬁndings make an
important contribution to the ﬁeld.
After taking into consideration a number of caveats, our results
represent one of the most detailed studies of the association
between cardiovascular risk factors and cycling activity. BMI,
Figure 3. Body mass index (kgm− 2) in men and women organised
by cycling volume ⩽ 23.3, 23.21–40, 40.01–61.2 and 461.2
MET-h/week. Data adjusted for age.
Table 2. Association between cycling volume and risk of diagnosed
hypertension
Cycling volume
(MET-h/week)
Cases/N Model 1 OR (95% CI) Model 2 OR (95% CI)
o23.2 233/1832 1.00 (ref) 1.00 (ref )
23.21–40.0 230/1791 0.98 (0.80–1.21) 1.08 (0.88–1.33)
40.01–61.2 193/1652 0.86 (0.70–1.06) 0.94 (0.76–1.16)
461.2 163/1674 0.67 (0.53–0.83) 0.79 (0.63–0.99)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; MET-h/week,
metabolic equivalent hours/week. Model 1: analyses adjusted for age and
sex; Model 2: analyses adjusted for age, sex, BMI, smoking, alcohol and
other moderate–vigorous physical activity.
Table 3. Association between cycling volume and risk of high
cholesterol
Cycling volume
(MET-h/week)
Cases/N Model 1 OR (95% CI) Model 2 OR (95% CI)
o23.2 260/1832 1.00 (ref) 1.00 (ref )
23.21–40.0 226/1791 0.84 (0.69–1.03) 0.89 (0.73–1.10)
40.01–61.2 205/1652 0.81 (0.66–0.99) 0.85 (0.69–1.05)
461.2 189/1674 0.70 (0.56–0.86) 0.78 (0.63–0.97)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; MET-h/week,
metabolic equivalent hours/week. Model 1: Analyses adjusted for age and
sex; Model 2: analyses adjusted for age, sex, BMI, smoking, alcohol and
other moderate–vigorous physical activity.
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hypertension and hypercholestrolaemia are well-recognised risk
factors for coronary heart disease18 and thus the implications of
increased cycling activity in the population may have profound
effects on mortality and morbidity secondary to cardiac disease.
Few studies have speciﬁcally examined associations between
cycling and cardiovascular disease, and the results are incon-
sistent. For example, in the Shanghai Women's Health Study,
cycling was associated with lower risk of all cause mortality but
not incident cardiovascular disease after accounting for other
types of physical activities.19 However, cycling volumes were
relatively low as the threshold for the highest category
(43.5 MET-h/day) barely reached the cut-off for the lowest
category in the present study. In a sample of Dutch adults where
75% reported regular cycling, there was an inverse association
between cycling and cardiovascular disease although no dose–
response was observed.7 And data from a large general
population sample of English adults provided mixed support for
beneﬁts of cycling in relation to mortality.20 Numerous studies
have examined associations between active commuting and
cardiovascular disease risk21,22 although the analyses have
often combined cycling with walking thus making it difﬁcult
to dissect the speciﬁc effects of cycling. Taken together,
extrapolating data on the health beneﬁts of cycling from general
population studies is problematic because of insufﬁcient
participation in cycling and relatively low cycling volumes. The
major strength of our study was the recruitment of cyclists
enabling us to examine detailed dose–response associations.
Nevertheless, caution should be taken when extrapolating
these data to the general population as the present sample of
habitual cyclists are unrepresentative in numerous ways, including
other favourable lifestyle habits (for example, low rates of
smoking ~ 3.6%). In the National Runners’ Health Study a similar
dose–response reduction in BMI, hypertension and hypercholes-
trolemia was observed with increased running-miles per week.8
However, where running may prohibit some people with existing
injuries or lifestyle limitations, cycling may be used as a reasonable
substitute.
In 2008, based on self-report survey just 39% of English men
and 29% of women who took part in the Health Survey for
England met physical activity guidelines.23 Cycling is accessible to
most of the population and offers a potentially low cost,
environmentally friendly solution to increase physical activity
levels, since it can be incorporated into people’s daily lives as
means of transport.4,24 Nevertheless, there is little emphasis on the
beneﬁts of exceeding minimum physical activity recommenda-
tions or guidance regarding the volume and type of exercise
required. This data, in addition to existing evidence, demonstrate
the beneﬁts of physical activity in reducing cardiovascular disease
risk factors in the population and emphasise the role of cycling in
this endeavour.
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